Investing.com - Femasys reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Femasys announced earnings per share of $-0.25 on revenue of $347.46K. Analysts polled by Investing.com anticipated EPS of $-0.26 on revenue of $342.67K.
Femasys shares are down 4.96% from the beginning of the year, still down 83.82% from its 52 week high of $7.60 set on November 11, 2021.
Femasys shares gained 5.13% in intra-day trade following the report.
Femasys follows other major Healthcare sector earnings this month
Femasys's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar